Related references
Note: Only part of the references are listed.Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
Jason H. Cheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Natural derivatives of curcumin attenuate the Wnt/β-catenin pathway through down-regulation of the transcriptional coactivator p300
Min-Jung Ryu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells
Claus Kordes et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease
Sarah Dunn et al.
BIOCHEMICAL JOURNAL (2008)
Curcumin: potential for hepatic fibrosis therapy?
M. A. O'Connell et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The first five years of the Wnt targetome
Annica Vlad et al.
CELLULAR SIGNALLING (2008)
Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes
Sophie Jacqueminet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Mechanisms of hepatic fibrogenesis
Scott L. Friedman
GASTROENTEROLOGY (2008)
Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome
Paul Holvoet et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Activation of peroxisome proliferator-activated receptor-γ by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells
Jianguo Lin et al.
LABORATORY INVESTIGATION (2008)
Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation
Yumei Fu et al.
MOLECULAR PHARMACOLOGY (2008)
De novo synthesis of glutathione is a prerequisite for curcumin to inhibit hepatic stellate cell (HSC) activation
Shizhong Zheng et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Wnt signaling enhances the activation and survival of human hepatic stellate cells
Sun Jung Myung et al.
FEBS LETTERS (2007)
The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPARγ in rat activated hepatic stellate cell in vitro
Yajun Zhou et al.
LABORATORY INVESTIGATION (2007)
WNT/β-catenin signaling in liver health and disease
Michael D. Thompson et al.
HEPATOLOGY (2007)
Oxidative stress biology and cell injury during type 1 and type 2 diabetes Mellitus
Kenneth Maiese et al.
CURRENT NEUROVASCULAR RESEARCH (2007)
Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells
Shizhong Zheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation
Hidekazu Tsukamoto et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Gene expression profile of quiescent and activated rat hepatic stellate-cells implicates Wnt signaling pathway in activation
Feng Jiang et al.
JOURNAL OF HEPATOLOGY (2006)
Functional interaction between peroxisome proliferator-activated receptor γ and β-catenin
Jiajian Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Lectin-like oxidized low-density lipoprotein receptor-1-mediated autophagy in human granulosa cells as an alternative of programmed cell death
Nicole Duerrschmidt et al.
ENDOCRINOLOGY (2006)
Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor
SZ Zheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis
JW Chen et al.
BIOCHEMICAL JOURNAL (2006)
Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): A critical player in the development of atherosclerosis and related disorders
JL Mehta et al.
CARDIOVASCULAR RESEARCH (2006)
PPARγ regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1
PC Chui et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The inhibitory mechanism of curcumin and its derivative against β-catenin/Tef signaling
CH Park et al.
FEBS LETTERS (2005)
Functional genomic analysis of the Wnt-Wingless signaling pathway
R DasGupta et al.
SCIENCE (2005)
Regulation of PPARγ activity during adipogenesis
SR Farmer
INTERNATIONAL JOURNAL OF OBESITY (2005)
Liver fibrosis
R Bataller et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Mechanistic role of cytochrome P450 monooxygenases in oxidized low-density lipoprotein-induced vascular injury - Therapy through LOX-1 receptor antagonism?
T Thum et al.
CIRCULATION RESEARCH (2004)
Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis
N Chalasani et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Activation of PPARγ is required for curcurnin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro
SZ Zheng et al.
BIOCHEMICAL JOURNAL (2004)
Biological properties of curcumin-cellular and molecular mechanisms of action
B Joe et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2004)
Peroxisome-proliferator-activated receptor γ suppresses Wnt/β-catenin signalling during adipogenesis
M Moldes et al.
BIOCHEMICAL JOURNAL (2003)
Activation of peroxisome proliferator-activated receptor-γ contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth
JY Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation
JL Mehta et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression
AP Chen et al.
BIOCHEMICAL JOURNAL (2002)
β-Catenin-mediated transactivation and cell -: cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells
AS Jaiswal et al.
ONCOGENE (2002)
Oxidized low-density lipoproteins bind to the scavenger receptor, CD36, of hepatic stellate cells and stimulate extracellular matrix synthesis
W Schneiderhan et al.
HEPATOLOGY (2001)
PPARγ ligands inhibit TNF-α-induced LOX-1 expression in cultured endothelial cells
Y Chiba et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes
S Ehara et al.
CIRCULATION (2001)
Peroxisome proliferator-activated receptors and hepatic stellate cell activation
T Miyahara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: Comparison of endpoint and real-time methods
TD Schmittgen et al.
ANALYTICAL BIOCHEMISTRY (2000)
Ligands of peroxisome proliferator-activated receptor γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells
F Marra et al.
GASTROENTEROLOGY (2000)
Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells - Evidence from use of antisense LOX-1 mRNA and chemical inhibitors
DY Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
A dominant-negative peroxisome proliferator-activated receptor γ (PPARγ) mutant is a constitutive repressor and inhibits PPARγ-mediated adipogenesis
M Gurnell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells
A Galli et al.
HEPATOLOGY (2000)
Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects
T Shoji et al.
ATHEROSCLEROSIS (2000)
Share Paper
